The average reduction in tumor size was 17% vs 12% in the mFOLF (3.31 cm pre‐NAT, 2.76 post‐NAT) vs nab‐P/G (3.79 cm pre‐NAT, 3.35 cm post‐NAT), respectively. The gene discussed is BRD2; the disease is neoplasm.